<DOC>
	<DOCNO>NCT01462708</DOCNO>
	<brief_summary>The purpose study ass MK-9470 Positron Emission Tomography ( PET ) image tool evaluate activity CB-1 receptor brain .</brief_summary>
	<brief_title>Evaluation 18FMK-9470 Brain Tracer Cannabinoid-1 Receptor Parkinson 's Disease Healthy Subjects</brief_title>
	<detailed_description>The underlying goal study assess MK-9470 PET image tool evaluate activity CB-1 receptor brain Parkinson 's Disease ( PD ) research participant .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Early PD Subjects Inclusion criterion : The participant 30 year old . Written inform consent obtain . Participants diagnosis PD ( base UK Brain Bank Criteria ) within past 2 year . Modified Hoehn Yahr stag 12 . No evidence dyskinesia history clinical examination For female , nonchild bear potential negative urine blood pregnancy test day [ 18F ] MK9470 injection . Advanced PD subject Inclusion criterion : The participant 30 year old . Written inform consent obtain . Participants diagnosis PD ( base UK Brain Bank Criteria ) least 5 year duration . Modified Hoehn Yahr stag 14 . No evidence dyskinesia history clinical examination For female , nonchild bear potential negative urine blood pregnancy test day [ 18F ] MK9470 injection . Subjects clinical diagnosis advance PD dyskinesia recruit study . ePD subject Inclusion criterion : The participant 30 year old . Written inform consent obtain . Participants diagnosis PD ( base UK Brain Bank Criteria ) least 5 year . Modified Hoehn Yahr stag 14 . Evidence dyskinesia either history clinical examination For female , nonchild bear potential negative urine blood pregnancy test day [ 18F ] MK9470 injection . PD ( stage ePD , aPD , aPDdys ) Subject Selection . Subjects clinical diagnosis ePD , aPD , aPDdys recruit study . All PD subject Exclusion criterion : The subject clinically significant abnormal laboratory value and/or clinically significant unstable medical psychiatric illness The subject disorder may interfere drug absorption , distribution , metabolism , excretion . The patient evidence unstable gastrointestinal , cardiovascular , hepatic , renal , hematological , neoplastic , endocrine , neurological , pulmonary , disorder disease . Evidence stroke mass lesion clinically relevant area may interfere image outcome measure Subjects radiation exposure acceptable level Pregnancy Healthy Control Subject Selection : subject neurological disease recruit study . Healthy control subject Inclusion criterion : The participant 18 year old . Written inform consent obtain . Negative history neurological psychiatric illness base evaluation research physician . For female , nonchild bear potential negative urine blood pregnancy test day [ 18F ] MK9470 injection . Exclusion criterion : The subject clinically significant abnormal laboratory value and/or clinically significant unstable medical psychiatric illness . The subject evidence clinically significant gastrointestinal , cardiovascular , hepatic , renal , hematological , neoplastic , endocrine , neurological , immunodeficiency , pulmonary , disorder disease . The subject disorder may interfere drug absorption , distribution , metabolism , excretion . Subjects radiation exposure acceptable level Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Parkinson Disease</keyword>
	<keyword>Molecular NeuroImaging</keyword>
</DOC>